Login / Signup

UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study.

Hideki MatsuokaRyusuke MurakamiKaoru AbikoKen YamaguchiAkihito HorieJunzo HamanishiTsukasa BabaMasaki Mandai
Published in: BMC cancer (2020)
Irinotecan chemotherapy might be beneficial in patients with cervical cancer, UGT1A1 polymorphisms, and ≤ 1 metastatic lymph nodes.
Keyphrases
  • lymph node
  • squamous cell carcinoma
  • locally advanced
  • small cell lung cancer
  • rectal cancer
  • sentinel lymph node
  • radiation therapy
  • chemotherapy induced